ES2118094T3 - Derivados del acido carbamico y procedimiento para su preparacion. - Google Patents

Derivados del acido carbamico y procedimiento para su preparacion.

Info

Publication number
ES2118094T3
ES2118094T3 ES92101449T ES92101449T ES2118094T3 ES 2118094 T3 ES2118094 T3 ES 2118094T3 ES 92101449 T ES92101449 T ES 92101449T ES 92101449 T ES92101449 T ES 92101449T ES 2118094 T3 ES2118094 T3 ES 2118094T3
Authority
ES
Spain
Prior art keywords
derivatives
carbamic acid
group
atom
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92101449T
Other languages
English (en)
Inventor
Yasuo Takano
Masanori Takadoi
Takashi Hirayama
Atsuhiro Yamanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2118094T3 publication Critical patent/ES2118094T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)

Abstract

SE DESCRIBEN MEDICAMENTOS ANTI-DEMENCIA COMPRENDIENDO DERIVADOS DE ACIDO CARBAMICO O DE SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES TENIENDO UNA ACTIVIDAD ANTI-AMNESICA, COMO INGREDIENTE ACTIVO. LOS DERIVADOS DE ACIDO CARBAMICO ESTAN REPRESENTADOS POR UNA FORMULA GENERAL (1) DONDE AR SIGNIFICA UN ANILLO HETEROCICLICO AROMATICO QUE PUEDE TENER AL MENOS UN SUSTITUYENTE O SU ANILLO DE BENZENO CONDENSADO, O GRUPO FENIL QUE PUEDE TENER AL MENOS UN SUSTITUYENTE, R ELEVADO 1 SIGNIFICA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO INFERIOR, R (AL CUADRADO) SIGNIFICA UN GRUPO ALQUILO INFERIOR QUE PUEDE SUSTITUIRSE CON UN ATOMO HALOGENO, GRUPO FENILO QUE PUEDE TENER AL MENOS UN SUSTITUYENTE, GRUPO NAFTILO, O UN ANILLO HETEROCICLICO DE CINCO O SEIS MIEMBROS Y SU ANILLO CONDENSADO DE BENZENO, X Y Y, QUE PUEDEN SER LO MISMO O DIFERENTE, SIGNIFICAN UN ATOMO DE SULFURO O ATOMO DE OXIGENO.
ES92101449T 1991-01-31 1992-01-29 Derivados del acido carbamico y procedimiento para su preparacion. Expired - Lifetime ES2118094T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3192291 1991-01-31
JP03007192A JP3169188B2 (ja) 1991-01-31 1992-01-21 カルバミン酸誘導体及びその製造方法

Publications (1)

Publication Number Publication Date
ES2118094T3 true ES2118094T3 (es) 1998-09-16

Family

ID=26368350

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92101449T Expired - Lifetime ES2118094T3 (es) 1991-01-31 1992-01-29 Derivados del acido carbamico y procedimiento para su preparacion.

Country Status (10)

Country Link
EP (1) EP0497303B1 (es)
JP (1) JP3169188B2 (es)
KR (1) KR960009429B1 (es)
CN (1) CN1054123C (es)
AU (1) AU643590B2 (es)
CA (1) CA2060393C (es)
DE (1) DE69225625T2 (es)
ES (1) ES2118094T3 (es)
HU (2) HUT60260A (es)
TW (1) TW199889B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522914A1 (fr) * 1991-06-27 1993-01-13 Synthelabo Dérivés de 2-pipéridinylpyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
DE19750401A1 (de) * 1997-11-14 1999-05-20 Bayer Ag Kondensierte Pyridin-Derivate
GB9822440D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB0218326D0 (en) * 2002-08-07 2002-09-11 Glaxo Group Ltd Compounds
KR100477987B1 (ko) 2002-09-11 2005-03-23 삼성에스디아이 주식회사 리튬-황 전지용 양극 및 이를 포함하는 리튬-황 전지
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators
FR2948368B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux composes piperidiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY36391A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (es) * 1977-06-03 1981-03-07 Pfizer
GB2021108B (en) * 1978-05-18 1982-07-21 Pfizer Ltd 6,7 - di - 4 - amino - 2 - quinazolines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
JPS63170356A (ja) * 1986-12-30 1988-07-14 Yamanouchi Pharmaceut Co Ltd アニリン誘導体及びその製造法

Also Published As

Publication number Publication date
DE69225625T2 (de) 1999-01-28
TW199889B (es) 1993-02-11
JP3169188B2 (ja) 2001-05-21
CN1064075A (zh) 1992-09-02
CN1054123C (zh) 2000-07-05
CA2060393A1 (en) 1992-08-01
CA2060393C (en) 2002-03-12
JPH0558999A (ja) 1993-03-09
EP0497303A3 (en) 1992-09-23
DE69225625D1 (de) 1998-07-02
AU643590B2 (en) 1993-11-18
HU222246B1 (hu) 2003-05-28
HU9200251D0 (en) 1992-04-28
EP0497303B1 (en) 1998-05-27
KR920014798A (ko) 1992-08-25
HUT60260A (en) 1992-08-28
AU1064992A (en) 1992-08-06
EP0497303A2 (en) 1992-08-05
KR960009429B1 (en) 1996-07-19

Similar Documents

Publication Publication Date Title
ES2055056T3 (es) Derivados de pirimidopirimidina.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
ATE156116T1 (de) Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2175127T3 (es) Derivados de la quinazolina y su uso.
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES2163071T3 (es) Sulfonamidas y su utilizacion.
ES2059383T3 (es) Compuestos de diamina.
AR007898A1 (es) Un compuesto derivado de la 4-hidroxi-piperidina, su empleo para la elaboracion de un medicamento, un procedimiento para prepararlo, y un medicamento que lo contiene.
ES2196344T3 (es) Derivados de sulfonamida y su uso en el tratamiento de trastornos de snc.
ES2150113T3 (es) Derivados de pirazol y procedimientos para la preparacion de los mismos.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2160648T3 (es) Derivados de piridina.
ES2053837T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico.
ES2118094T3 (es) Derivados del acido carbamico y procedimiento para su preparacion.
ES2061953T3 (es) Un procedimiento para preparar una composicion farmaceutica.
MX9205123A (es) Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios.
ES2035848T3 (es) Nuevos derivados de acido 1-heterociclil-h-imidazol-5-carboxilico.
ES2058177T3 (es) Nuevos derivados de alcanosulfonanilida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
AR027578A1 (es) Derivados de indano
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 497303

Country of ref document: ES